Get the free weekly executive digest
The new leadership moves, who’s behind them, and what they mean — delivered to your inbox every week. No credit card, unsubscribe anytime.
New leadership moves, summarized for you
No login, no app to check — it comes to you
See who's moving and how much in your market
Zenas Bio Pharma Appoints Lisa Von Moltke, M.D. As Head of Research and Development and Chief Medical Officer
Position
Head of Research and Development
Company
Zenas BioPharma
WalthamBiotechnologyHealth CareTherapeuticsDescription
Zenas BioPharma, Inc announced the appointment of Lisa von Moltke, MD, as its new Head of Research and Development and Chief Medical Officer. Dr von Moltke brings over three decades of experience in drug development, with expertise in autoimmune diseases, to the Zenas leadership team. Her immediate focus will be on advancing Zenas’s lead product candidate, obexelimab, through critical Phase 2 and Phase 3 clinical trials for autoimmune diseases such as IgG4-related disease, multiple sclerosis, and systemic lupus erythematosus.